4.790
+5,97%
2026-10-19
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -60.9% | -52.6% | 1 / 3 | +40.5% | -2.35 pp | -0.43 pp | +0.4% | 0.26 | 117.65 | 71,4 | +40,5% | 0,1 | −60,9% | 117.65 | 3.40 | +3.360,4% |
| Pts | 0 | 0 | 4 | 12 | 4 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 4.790 (close price on 2026-10-19)EPS (TTM): 40,7
Financial charts
1.Revenue & growth
VND bn71,4Q2/26
1.Revenue & growth
VND bn71,4Q2/26
2.Profit & growth
VND bn0,14Q2/26
3.Profit mix (Penman)
VND bn1,15Q2/26
4.Margins & cost structure
%3.1%Q2/26
5.Returns & cash cycle
% · days2.0%Q2/26
6.Earnings quality & cash
VND bn3,17Q2/26
7.Asset structure
VND bn338Q2/26
8.Funding & debt health
VND bn · times338Q2/26
9.Revenue backlog
VND bn4,02Q2/26
10.Valuation
times · %115,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %5Q2/26
Adjusted EPS growth, latest quarter
-52.9%
Average adjusted EPS growth, 3 quarters
-49.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26